Scientific Information

Congress Committees

Presidents

Scientific Programme

08:00-09:00

Registration

09:00-09:15

Introduction and welcome

Daniela Prayer (Austria) and Yves Ville (France)

Chair: Reuven Achiron (Israel), Barbara Ulm (Austria)

09:15-09:35

What information needs a pediatric cardiac surgeon from imaging studies?

Team Daniel Zimpfer

09:35-09:55

Imaging of the fetal vessels

Reuven Achiron, Israel

09:55-10:15

MRI of the fetal heart. where are we now?

Vanessa Berger- Kuleman, Austria

10:15-10:35

Cardiovascular MRI. How can we learn the most from postmortem studies?

Gerlinde Gruber, Austria and Gregor Dovjak, Austria

10:35-11:00

BREAK

Chair: Rabih Chaouih (Germany), Vanessa Berger- Kulemann (Austria)

11:00-11:20

Where are the limits of US?

Barbara Ulm, Austria

11:20-11:40

Innovations in Cardiovascular US

Simcha Yagel, Israel

11:40-12:00

First Transition in Congenital Heart Disease, from Fetus to Neonate

Elisabeth Mlczoch, Austria

12:00-12:20

Congenital heart disease and preterm birth – what innovative interventional concepts can we offer?

Ina Michel-Behnke, Austria

12:20-12:50

Oral communications

12:50-14:00

LUNCH BREAK

13:40-15:00

VENTRICULOMEGALY AND ACQUIRED CONDITIONS

Chair: Denise Pugash, Gustavo Malinger (Israel)

14:00-14:20

Prenatal ventriculomegaly and postnatal outcome

Elisenda Eixarch, Spain

14:20-14:40

Ventriculomegaly- what now?

Gustavo Malinger , Austria

14:40-15:00

Infratentorial anomalies and ventriculomegaly. dedicated US.

Karina Krajden Haratz, Israel

15:00-15:20

Infratentorial anomalies and ventriculomegaly can MRI still add something?

Gregor Kasprian, Austria

15:20-15:40

Chiari II. prenatal therapy and postnatal outcome.

Magda Sanz- Cortez, United States

15:40-16:00

BREAK

Chair: Yves Ville (France), Daniela Prayer (Austria)

16:00-16:20

Ventriculomegaly in acquired conditions.

Mariana Diogo

16:20-17:10

Oral communications

17:10-17:30

Prenatal CMV and postnatal outcome.

Yves Ville, France

08:30-10:00

COMMISSURAL ABNORMALITIES

Chair: Karina Krajden-Haratz (Israel), Elisabeth Krampl-Bettelheim

08:30-08:50

Isolated Corpus Callosum agenesis. when is it clear on US?

Gustavo Malinger, Israel

08:50-09:10

US of complex cases with commissural abnormalities

Karina Krajden Haratz, Israel

09:10-09:30

MR-approach to CC agenesis

Christian Mitter, Austria

09:30-09:45

The value of fetal tractography in short corpus callosum: the Necker experience

Anne-Elodie Millischer, France

09:45-10:05

Oral Communications

10:05-10:30

BREAK

10:30-12:30

COMMISSURAL ABNORMALITIES

Chair: Tania Attie-Biach (France), Gregor Kasprian (Austria)

10:30-10:50

Prognosis in Commissural Abormalities MR score and neurodevelopmental assessment

Rainer Seidl and Gregor Kasprian, Austria

10:50-11:10

“Bad“ genes- “bad“ outcome?

Tania Attie- Bitach, France

11:10-11:30

Language development in commissural agenesis

Lisa Bartha- Doering, Austria

11:30-12:30

Oral communications

12:30-13:30

LUNCH BREAK

13:30-15:00

NEW DEVELOPMENTS AND BIG DATA

Chair: Laurent Salomon (France), Georg Langs (Austria)

13:30-13:50

Machine learning approaches to disentangle development and disease from large cohorts - a primer

Roxane Licandro, Austria

13:50-14:10

Population models of fetal brain development

Georg Langs, Austria

14:10-14:20

Modelling the development of the functional fetal connectome in utero

Athena Taymourtash, Austria

14:20-14:30

Developmental atlas building taking biomechanics into account

Ernst Schwartz, Austria

14:30-14:45

Beyond geometry - capturing topology, gyration, and mechanics between development and evolution

Roberto Toro, France

14:45-15:10

COFFEE BREAK

15:10-15:25

Studying the placenta across individuals

Jana Hutter, United Kingdom

15:25-15:40

Arterial Spin Labelling: techniques, strengths and limitations in exploring pregnancy

David Grévent, France

15:40-15:55

Functional MRI of the placenta: where are we now?

Laurent Salomon, France

16:00-17:40

(POTENTIALLY) TREATABLE CONDITIONS

Chair: Peter C Brugger (Austria)

16:00-16:40

Ultrasound of potentially treatable conditions

Elisabeth Krampl- Bettelheim, Austria

16:40-17:00

Omphalocele- a MR- indication?

Peter C Brugger, Austria

17:00-17:20

MRI of potentially treatable conditions

Florian Prayer, Austria

17:20-17:40

Oral communications

Parallel Session

13:00-17:30

NEW: SPECIAL TRACK FOR TECHNOLOGISTS

Christian Lindner, Judith Kurz, Rebecca Mittermaier, Friedrich Stuhr, Austria

13:00-14:00

Fetal development: from head to toe

14:00-15:00

Technical requirements and patient handling

15:00-15:30

BREAK

15:30-16:30

Tips and tricks for the fetal MR examination (troubleshooting)

16:30-17:30

Questions and answers

09:30-11:40

MR IMAGE QUALITY

Chair: Daniela Prayer (Austria), Johannes Streicher

09:30-09:50

Optimal techniques for optimal results

Peter Brugger, Austria

09:50-10:10

the ISUOG guidelines for fetal MRI

Daniela Prayer, Austria

10:10-10:30

T1 contrast. why and how

Gregor Dovjak, Austria

10:30-11:00

Tractography for dummies

Christian Mitter, Austria

11:00-11:20

BREAK

11:20-11:40

Best presentation rewards

THE FETAL HEART

Prenatal cardiovascular imaging has been a domain of ultrasound so far. New MR- methods allow to provide supplementary informations. The combined application of both methods means a big step forward with respect to information of the cardiac surgeon and individual prognosis.

VENTRICULOMEGALY AND ACQUIRED CONDITIONS

Prenatal imaging of ventriculomegaly is still discussed controversially. Do we need MRI? Is ultrasound alone sufficient? Is the condition the consequence of a malformative process or acquired? How can a patient be counseled and /or treated ? All these questions will be addressed.

COMMISSURAL ABNORMALITIES

Abnormalities of the corpus callosum may or may not be associated with an adverse neuropsychological outcome.  Imaging methods combined with genetic testing have to be used together to achieve a most accurate prognosis. In addition, postnatal research helps to define possible deficits.

NEW DEVELOPMENTS AND BIG DATA

Prenatal imaging methods develop consistently, producing a myriad of data. Consequently machine learning methods are applied and help to establish a new view on early brain development and deviations thereof

(POTENTIALLY) TREATABLE CONDITIONS

Surgical and drug therapy has been applied successfully in different fetal pathologic states. The challenge for prenatal diagnosis is to recognize treatable conditions timely.

MR IMAGE QUALITY

Optimal image quality requires a profound knowledge of MR techniques and correct application of the respective sequences. In addition post-processing may help to answer certain questions.

Invited Speakers

Invited speakers

 
 
 
 
 
 
 
 
 
 
 

Accreditations

CVS Ethical Medtech

the EMT20409 Ultrasound meets Magnetic Resonance starting on 03-09-2020 in Vienna, Austria, is  provisionally compliant with the MedTech Europe Code of Ethical Business.

Please note that the Pre-Clearance is a preliminary stage of the assessment process, it allows Medtech members to initiate discussions with the event organiser on providing financial support of the event whether via an educational grant or commercial activities.

CME Accreditation

An application will be sent to EACCME®

More information will be available soon